These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31548996)

  • 1. Immunoglobulin for Kawasaki disease: a 3-year retrospective audit.
    Pascall B; Thakker A; Foo Y; Thakker P
    BMJ Paediatr Open; 2019; 3(1):e000451. PubMed ID: 31548996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease at British Columbia's Children's Hospital.
    Ebbeson RL; Riley MR; Potts JE; Human DG; Malleson PN
    Paediatr Child Health; 2004 Sep; 9(7):466-70. PubMed ID: 19657410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.
    Yellen ES; Gauvreau K; Takahashi M; Burns JC; Shulman S; Baker AL; Innocentini N; Zambetti C; Pancheri JM; Ostrow A; Frazer JR; Sundel RP; Fulton DR; Newburger JW
    Pediatrics; 2010 Feb; 125(2):e234-41. PubMed ID: 20100771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes.
    Jaggi P; Grcic M; Kovalchin J; Wilhelm CM; Yildirim-Toruner C; Texter K
    J Pediatric Infect Dis Soc; 2018 May; 7(2):119-123. PubMed ID: 28383697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease in adults: report of 10 cases.
    Gomard-Mennesson E; Landron C; Dauphin C; Epaulard O; Petit C; Green L; Roblot P; Lusson JR; Broussolle C; Sève P
    Medicine (Baltimore); 2010 May; 89(3):149-158. PubMed ID: 20453601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki Disease in the Australian Population: An Australian Tertiary Hospital Experience.
    Ferreira D; Ng R; Lai E; Singh-Grewal D; Kehr J; Collins N; Thomson Bowe K
    Heart Lung Circ; 2021 Jul; 30(7):996-1001. PubMed ID: 33612428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic characteristics of supplemental laboratory criteria for incomplete Kawasaki disease in children with complete Kawasaki disease.
    Jun HO; Yu JJ; Kang SY; Seo CD; Baek JS; Kim YH; Ko JK
    Korean J Pediatr; 2015 Oct; 58(10):369-73. PubMed ID: 26576180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days.
    Hu YC; Liu HM; Lin MT; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    Front Pediatr; 2019; 7():158. PubMed ID: 31069204
    [No Abstract]   [Full Text] [Related]  

  • 16. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Demographic, Clinical, and Echocardiographic Features Between Complete and Incomplete, and Early and Late Presenters of Kawasaki Disease: A 10-Year Single-Center Experience.
    Kolko N; Bhat YA; Al Mesned A; Al Qwaee A; Al Akhfash A; Alhobani M; Al Anazi I
    Cureus; 2023 Sep; 15(9):e45819. PubMed ID: 37876391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Kawasaki Disease Complicated With Coronary Artery Aneurysm: A Case Report and Review of Literature.
    Tanti SK; Mishra S
    Cureus; 2021 Feb; 13(2):e13589. PubMed ID: 33815991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
    JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.